September 19, 2014 8:53 PM ET

Pharmaceuticals

Company Overview of Attenuon, LLC

Company Overview

Attenuon, LLC, a clinical-stage biopharmaceutical company, develops cancer therapeutics to disrupt cellular signaling processes to tumor growth and metastatsis. It offers ATN-224 that disrupts signaling pathways involved in tumor growth, angiogenesis, and metastasis, including those mediated by multiple kinases, as well as NF-kappaB by inhibiting the enzyme superoxide dismutase; and ATN-161, a five-amino acid peptide derived from fibronectin. The company was founded in 1998 and is based in San Diego, California.

11535 Sorrento Valley Road

Suite 401

San Diego, CA 92121

United States

Founded in 1998

Phone:

832-813-5014

Fax:

858-720-1086

Key Executives for Attenuon, LLC

Chief Operating Officer
Senior Vice President
Chief Medical Officer
Chief Business Officer
Age: 54
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Nascime Limited United States
Genemed Biotechnologies, Inc. United States
Viral Oncotherapies, Inc United States
Aptalis Pharma Inc. United States
MacuHealth, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Attenuon, LLC, please visit www.attenuon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.